1. Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types
- Author
-
Ramita Dewan, Mike A. Nalls, Sarah Ahmed, Sara Bandres-Ciga, Bryan J. Traynor, Ruth Chia, Yevgeniya Abramzon, Italsgen, Mina Ryten, Sara Saez-Atienzar, Mark R. Cookson, Regina H. Reynolds, John Landers, Shing Wan Choi, Jonggeol J. Kim, Rebekah G. Langston, and Adriano Chiò
- Subjects
Cell type ,Disease ,Biology ,Polymorphism, Single Nucleotide ,Genetic analysis ,Biological pathway ,03 medical and health sciences ,0302 clinical medicine ,Neuron projection morphogenesis ,Mendelian randomization ,Genetics ,medicine ,Humans ,Genetic Testing ,Amyotrophic lateral sclerosis ,Research Articles ,030304 developmental biology ,0303 health sciences ,Multidisciplinary ,Amyotrophic Lateral Sclerosis ,SciAdv r-articles ,medicine.disease ,Signal transduction ,Neuroscience ,030217 neurology & neurosurgery ,Research Article ,Genome-Wide Association Study - Abstract
Massive genetic analysis identifies critical pathways and cell types involved in pathogenesis of amyotrophic lateral sclerosis., Despite the considerable progress in unraveling the genetic causes of amyotrophic lateral sclerosis (ALS), we do not fully understand the molecular mechanisms underlying the disease. We analyzed genome-wide data involving 78,500 individuals using a polygenic risk score approach to identify the biological pathways and cell types involved in ALS. This data-driven approach identified multiple aspects of the biology underlying the disease that resolved into broader themes, namely, neuron projection morphogenesis, membrane trafficking, and signal transduction mediated by ribonucleotides. We also found that genomic risk in ALS maps consistently to GABAergic interneurons and oligodendrocytes, as confirmed in human single-nucleus RNA-seq data. Using two-sample Mendelian randomization, we nominated six differentially expressed genes (ATG16L2, ACSL5, MAP1LC3A, MAPKAPK3, PLXNB2, and SCFD1) within the significant pathways as relevant to ALS. We conclude that the disparate genetic etiologies of this fatal neurological disease converge on a smaller number of final common pathways and cell types.
- Published
- 2021
- Full Text
- View/download PDF